HLN Stock Analysis: Buy, Sell, or Hold?
HLN - Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$10.47
0.17 (1.65%)
▲
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
25d
Get Alerted When HLN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: HLN shows positive signals but monitor for confirmation. Market pricing in 0.4% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: HLN shows positive signals but monitor for confirmation. Market pricing in 0.4% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$14.27
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$8.86
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 18.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HLN is currently trading at $10.47, which is considered extended relative to its 30-day fair value range of $9.92 to $10.32. The stock's valuation (Forward PE: 18.8) is in line with its historical norms (18.5). At these levels, the market is pricing in 0.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, HLN is in a strong downtrend. The price is approaching resistance at $10.57. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: HLN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.82 (+14.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, HLN is in a strong downtrend. The price is approaching resistance at $10.57. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: HLN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.82 (+14.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$9.92 -
$10.32
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
60.5%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($11.82)
- NEUTRAL: Market pricing in 0.4% annual earnings growth - fairly valued
Fair Price Analysis
30-Day Fair Range
$9.92 -
$10.32
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$9.74
Resistance Level
$10.57
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
18.75
Wall Street Target
$11.82
(+14.8%)
Revenue Growth (YoY)
-1.3%
Earnings Growth (YoY)
34.8%
Profit Margin
13.8%
Valuation Premium vs History
+0.4% premium
PE vs Historical
18.8 vs 18.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.4%
(market-implied from PE analysis)
1-Year Target
$10.34
(+0%)
2-Year Target
$10.38
(+1%)
3-Year Target
$10.42
(+1%)
3-Yr Target (if PE normalizes)
(PE: 19→19)
PE COMPRESSION
$10.28
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 10.1%)
$16.34
(+59%)
Base:
(SPY PE: 18.8, Growth: 10.1%)
$13.74
(+33%)
Bear:
(PE: 15.9, Growth: 10.1%)
$11.68
(+13%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (22x PE), but valuation improves significantly next year (19x PE) as earnings recover.
Trailing PE: 22.41 | Current EPS (TTM): $0.46
Bull Case
$13.54
(+29%)
Analyst growth 19.4%, PE expands to 24.7
Base Case
$12.31
(+18%)
Market implied 19.4%, PE stable at 22.4
Bear Case
$7.01
(-33%)
Severe decline -20.0%, PE contracts to 19.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Last updated: January 31, 2026 4:36 AM ET
Data refreshes hourly during market hours. Next update: 5:36 AM
Data refreshes hourly during market hours. Next update: 5:36 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HLN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$179 | 62 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$158 | 56 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$84 | 57 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 55 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$21 | 57 HOLD |
Advanced HLN Option Strategies
Professional options setups generated by AI based on today's HLN price and gamma walls.
